Provider Statement

This continuing medical education activity is provided by 

Educational Partner

Support Statement

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Activity Chair

Andrew Blauvelt, MD, MBA
Oregon Medical Research Center 
Portland, OR

Scientific Adviser and Clinical Study Investigator: AbbVie, Amgen, Boehringer-Ingelheim, Celgene, Dermira, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, Sun, UCB, Valeant
Received Non-CME Services Fee: Lilly


Kenneth B. Gordon, MD
Professor of Dermatology
Northwestern University, Feinberg School of Medicine
Chicago, IL

Consulting Fee: AbbVie, Amgen, Celgene, Boeringher-Ingelheim, Dermira, Eli Lilly, Janssen, Pfizer, Novartis
Contracted Research: AbbVie, Amgen, Celgene, Boeringher Ingelheim, Eli Lilly, Janssen


Farah Rukhsana Abdulla, MD
Assistant Professor of Medicine
University of Chicago Medicine
Contracted Research: Actelion, Bristol-Myers Squibb

Linda A. Giarraputo, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education and University of Chicago staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at The University of Chicago Pritzker School of Medicine.


In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CME/CE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME/CE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CE activity content over which the individual has control. Relationship information appears above.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Physician Information

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Information

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID 16102373

This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Assistant Information

This program has been reviewed and is approved for a maximum of 1.0 hours of AAPA clinical Category 1 CME credit by the PA Review Panel. Approval is valid for 1 year from the date of 11/8/2016. Participants may submit the posttest at any time during that period.

This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Materials.

This enduring material is approved for 1 year from the date of original release, November 8, 2016 to November 8, 2017.

How to Participate in this Activity and Obtain CME/CE Credit

To participate in this CME/CE activity, you must read the objectives, view the presentations, complete the posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, The University of Chicago Pritzker School of Medicine will issue a credit certificate.


Plaque psoriasis is a debilitating, noncurable autoimmune disorder, having a significant impact on quality of life, associated with depression, anxiety, social isolation, unemployment, and suicide. Various therapies, such as topical formulations and phototherapy, are currently available. The latest breakthroughs in understanding the immunopathology underlying plaque psoriasis include the identification of interleukins (IL-17, IL-22, and IL-23), which drive the chronic inflammatory nature of the disease. Multiple types of therapies in several drug classes are available and more are in the pipeline. In this Rapid Response activity, the latest evidence from the 2016 European Academy of Dermatology and Venereology Congress meeting on the efficacy and safety of new and emerging therapies for plaque psoriasis will be examined.

Target Audience

The intended audience for the activity is dermatology physicians, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with psoriasis.

Purpose/Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Examine new evidence regarding treatment selection for plaque psoriasis based on disease severity and how the mechanisms of action of new and emerging therapies target the immunological pathways of the disease.
  • Analyze the latest efficacy data of new and emerging therapies for plaque psoriasis, including small-molecule inhibitors and immunotherapy.
  • Evaluate the latest safety data pertaining to the use of immunotherapy in the treatment of plaque psoriasis to assist in the development of strategies to prevent, recognize, and effectively manage potential adverse effects.

Copyright Statement

Created and published by University of Chicago and Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME/CE Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.